@article{d10b61f706484ff48109cb33008dd87c,
title = "Limited significance of antifactor H antibodies in patients with membranous nephropathy",
author = "{MENTOR Study Investigators} and Amit Sethi and Jing Miao and Willrich, {Maria Alice V.} and Frinack, {Jody L.} and Cattran, {Daniel C.} and Fervenza, {Fernando C.}",
note = "Funding Information: The Membranous Nephropathy Trial of Rituximab (MENTOR) was supported by the Fulk Family Foundation and Genentech Inc. Funding Information: The study was funded by the Mayo Nephrology Collaborative Group – Mayo Clinic Foundation and the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.",
year = "2021",
month = jun,
doi = "10.2215/CJN.16631020",
language = "English (US)",
volume = "16",
pages = "939--941",
journal = "Clinical Journal of the American Society of Nephrology",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "6",
}